Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04249505 · ClinicalTrials.gov registry record
Refractive Accuracy of "2WIN" and Portable Autorefractors
A clinical trial, sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 708
- Enrollment target
NCT04249505 is a clinical trial that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 708 participants.
The verdict
NCT04249505 has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 708 participants
- Enrollment target
Study Summary
Youth and some adults have photoscreening refractions and hand-held auto refraction before cycloplegia refraction during new and follow up eye examinations. Vector math is applied to each refraction to determine how closely the hand-held "dry" devices match actual refraction.
Interventions
- DEVICE "2WIN" Photoscreener
- DEVICE "Plusoptix A12"
- DEVICE "Retinomax"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 708 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2021-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04249505
The ClinicalTrials.gov registry entry for NCT04249505 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 708 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alaska Blind Child Discovery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which "2WIN" Photoscreener is the first listed.
NCT04249505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04249505 about?
NCT04249505 is a clinical study titled "Refractive Accuracy of "2WIN" and Portable Autorefractors". Youth and some adults have photoscreening refractions and hand-held auto refraction before cycloplegia refraction during new and follow up eye examinations. Vector math is applied to each refraction to determine how closely the hand-held "dry" devices match actual refraction.
What is the current status of trial NCT04249505?
This trial is currently completed. The enrollment target is 708 participants. The study started on 2020-01-09. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT04249505?
The interventions under investigation include: "2WIN" Photoscreener (DEVICE), "Plusoptix A12" (DEVICE), "Retinomax" (DEVICE).
Who is sponsoring clinical trial NCT04249505?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.